Skip to main content

Research Repository

Advanced Search

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response

Al-kaabi, M.M.; Alshareeda, A.T.; Jerjees, D.A.; Muftah, A.A.; Green, A.R.; Alsubhi, N.H.; Nolan, C.C.; Chan, S.; Cornford, E.; Madhusudan, S.; Ellis, I.O.; Rakha, E.A.

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response Thumbnail


Authors

M.M. Al-kaabi

A.T. Alshareeda

D.A. Jerjees

A.A. Muftah

N.H. Alsubhi

C.C. Nolan

S. Chan

E. Cornford

I.O. Ellis

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology



Citation

Al-kaabi, M., Alshareeda, A., Jerjees, D., Muftah, A., Green, A., Alsubhi, N., …Rakha, E. (2015). Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response. British Journal of Cancer, 112(5), 901-911. https://doi.org/10.1038/bjc.2014.576

Journal Article Type Article
Acceptance Date Sep 23, 2014
Online Publication Date Feb 17, 2015
Publication Date 2015-03
Deposit Date Oct 17, 2018
Publicly Available Date Oct 17, 2018
Journal British Journal of Cancer
Print ISSN 0007-0920
Electronic ISSN 1532-1827
Publisher Cancer Research UK
Peer Reviewed Peer Reviewed
Volume 112
Issue 5
Pages 901-911
DOI https://doi.org/10.1038/bjc.2014.576
Public URL https://nottingham-repository.worktribe.com/output/1171615
Publisher URL https://www.nature.com/articles/bjc2014576
Contract Date Oct 17, 2018

Files






You might also like



Downloadable Citations